P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY

Bibliographic Details
Main Authors: Jing Lu, Huifen Zhou, Xin Zhou, Yonggong Yang, Laigen Tong, Miao Miao, Xiaofei Yang, Suning Chen
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b
_version_ 1797280128310444032
author Jing Lu
Huifen Zhou
Xin Zhou
Yonggong Yang
Laigen Tong
Miao Miao
Xiaofei Yang
Suning Chen
author_facet Jing Lu
Huifen Zhou
Xin Zhou
Yonggong Yang
Laigen Tong
Miao Miao
Xiaofei Yang
Suning Chen
author_sort Jing Lu
collection DOAJ
first_indexed 2024-03-07T16:36:44Z
format Article
id doaj.art-c6a9bc8f1f45419ab3ca50dbc4ba9672
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:44Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c6a9bc8f1f45419ab3ca50dbc4ba96722024-03-03T09:43:31ZengWileyHemaSphere2572-92412023-08-017e209492b10.1097/01.HS9.0000968512.20949.2b202308003-00302P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDYJing Lu0Huifen Zhou1Xin Zhou2Yonggong Yang3Laigen Tong4Miao Miao5Xiaofei Yang6Suning Chen71 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China2 Wuxi People’s Hospital Affiliated to Nanjing Medical University, Department of Hematology, WuXi, China3 The Affiliated Drum Tower Hospital of Nanjing University Medical School, Department of Hematology, Nanjing, China4 Yixing People’s Hospital, The Affiliated Hospital of Jiangsu University, Department of Hematology, Yixing, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, Chinahttp://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b
spellingShingle Jing Lu
Huifen Zhou
Xin Zhou
Yonggong Yang
Laigen Tong
Miao Miao
Xiaofei Yang
Suning Chen
P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
HemaSphere
title P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
title_full P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
title_fullStr P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
title_full_unstemmed P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
title_short P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
title_sort p401 innovative reduced dose chemotherapy followed by blinatumomab induction therapy for successful management of treatment naive b cell acute lymphoblastic leukemia adults a multicenter real world study
url http://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b
work_keys_str_mv AT jinglu p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT huifenzhou p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT xinzhou p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT yonggongyang p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT laigentong p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT miaomiao p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT xiaofeiyang p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy
AT suningchen p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy